Researchers at University of Tsukuba have identified multiple T-cell subtypes with unique characteristics in follicular lymphoma, a prevalent type of blood cancer. These T cells regulate the ...

Twenty years. That's how long Robert Oman has been cancer-free, thanks to a clinical trial offered at the University of Rochester's Wilmot Cancer Institute. And he isn't alone: 70% of patients in the ...

Cancer survivors may experience anxiety over minor illnesses, fearing recurrence despite being in remission. The "positivity trap" can make survivors feel invalidated, as constant reassurance may ...

Wednesday, the FDA granted accelerated approval to Bristol Myers Squibb Co’s (NYSE:BMY) Breyanzi (lisocabtagene maraleucel; liso-cel), a CD19-directed chimeric antigen receptor (CAR) T cell therapy, ...

Unlike some other forms of lymphoma, advanced stage follicular lymphoma is considered incurable. But a new analysis of long-term data on patients treated for the disease years ago with standard ...

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. A 25-year-old middle-distance runner diagnosed with an incurable form ...

Feeling like others have it worse can dismiss the real challenges of follicular lymphoma and leave patients without the support they need. I share how my dog helped me through treatment during the ...

Researchers conducting a Phase 2 clinical trial at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine say a new combination of antibody therapies produced a ...

CAR T-cell therapy is a cancer treatment that works by helping your immune system do its job better. It’s currently offered only once you’ve tried at least two other chemotherapies that didn’t work.